FDA Approves First Generic Version of Tussionex

Tris Pharma Oct. 7 announced that the Food and Drug Administration has approved the first generic version of UCB’s Tussionex.

Tussionex is a prescription cough medicine containing hydrocodone, a narcotic ingredient, and the antihistamine chlorpheniramine, according to FDA’s website.

Par Pharmaceutical has begun the shipment of the product under an exclusive distribution agreement, Monmouth Junction, N.J.-based Tris Pharma said.